Notice2026-18822
National Cancer Institute; Notice of Closed Meeting
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
September 15, 2026
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 91 Issue 177 (Tuesday, September 15, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 177 (Tuesday, September 15, 2026)]
[Notices]
[Page 58463]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-18822]
[[Page 58463]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the Board of Scientific
Counselors, National Cancer Institute.
The meeting will be closed to the public as indicated below in
accordance with the provisions set forth in section 552b(c)(6), Title 5
U.S.C., as amended for the review, discussion, and evaluation of
individual intramural programs and projects conducted by the National
Cancer Institute, including consideration of personnel qualifications
and performance, and the competence of individual investigators, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Name of Committee: Board of Scientific Counselors, National
Cancer Institute.
Date: November 9-10, 2026.
Time: 10:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate personnel qualifications and
performance, and competence of individual investigators.
Address: National Institutes of Health, National Cancer
Institute, 9609 Medical Center Drive, Rockville, MD 20850.
Meeting Format: Virtual Meeting.
Contact Person: Mehrdad M. Tondravi, Ph.D., Chief Institute
Review Office, National Cancer Institute, National Institutes of
Health, 9609 Medical Center Drive, Room 2W-464 MSC 9711, Rockville,
MD 20852, 240-276-5664, <a href="/cdn-cgi/l/email-protection#53273c3d372132253a3e133e323a3f7d3d3a3b7d343c25"><span class="__cf_email__" data-cfemail="74001b1a100615021d193419151d185a1a1d1c5a131b02">[email protected]</span></a>.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
Information is also available on the Institute's/Center's home
page: <a href="https://deainfo.nci.nih.gov/advisory/bsc/index.htm">https://deainfo.nci.nih.gov/advisory/bsc/index.htm</a>, where an
agenda and any additional information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support Grants; 93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health, HHS).
Dated: September 10, 2026.
Kuleni D. Onnen,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2026-18822 Filed 9-14-26; 8:45 am]
BILLING CODE 4167-05-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on September 15, 2026.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.